Xenotransplantation Risk Assessment

Definition

Definition: Xenotransplantation Risk Assessment is the systematic process of identifying, analyzing, and evaluating the potential public health and individual patient risks associated with transplanting living…

Definition: Xenotransplantation Risk Assessment is the systematic process of identifying, analyzing, and evaluating the potential public health and individual patient risks associated with transplanting living cells, tissues, or organs from animals into human recipients. Its primary goal is to prevent the transmission of novel zoonotic pathogens (xenozoonoses) and other adverse events.

Xenotransplantation offers a promising solution to the critical shortage of human organs for transplantation, utilizing genetically modified animals, primarily pigs, as donors. However, this innovative medical procedure introduces significant public health concerns, predominantly the risk of cross-species transmission of infectious agents, known as xenozoonoses. These pathogens, which could include viruses (e.g., porcine endogenous retroviruses or PERVs), bacteria, fungi, or parasites, might be harmless in their animal hosts but could potentially cause severe or novel diseases in human recipients. Furthermore, there is a theoretical risk of these transmitted agents adapting to humans and subsequently spreading within the general human population, potentially leading to epidemics or pandemics.

Advertisement

A comprehensive Xenotransplantation Risk Assessment involves a multidisciplinary approach encompassing rigorous pre-clinical research, stringent donor animal screening, and long-term post-transplant recipient monitoring. Donor animals are typically bred in highly controlled, specific pathogen-free (SPF) environments and may undergo genetic modifications to reduce immunogenicity and the risk of pathogen transmission. The assessment also considers the potential for immune rejection, physiological incompatibilities, and the ethical implications of using animal donors. Public health agencies play a crucial role in developing regulatory guidelines and surveillance strategies to mitigate these risks, ensuring that the potential life-saving benefits of xenotransplantation are pursued without compromising broader public health security.

Key Context:

  • Xenozoonoses
  • One Health Approach
  • Biosecurity Measures